Collaboration Details

Title of Collaborative Activity:

Development of In-Vitro Assays to Assess the Potency of Botulinum Neurotoxin Type A

Description of Collaborative Activity:

This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop new non-animal-based assays to assess the potency of botulinum neurotoxin type A (BoNT/A) in a Good Manufacturing Practice (GMP) commercial environment. (STTR [R41/R42]) [PA-09-178], (SBIR [R43/R44]) [PA-09-179].

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

2010

NIH Participating Institutes/Centers/Office of the Director:

NIAID, NINDS

HHS Agency Collaborators on this Activity:

FDA